| 2025 |
Pang, Y., Lyons, S. A., Nottingham Chaplin, P. K., Block, S. S., Fishman, D., Ciner, E. B., . . . Toulouse, S. (2025). Recommended practices for vision screening in pre-school-age children: A 2025 update. Optometry and Vision Science.
DOI |
| 2025 |
Chen, H. Y., Knoll, C., Boventer, E., Pratt, N., Anand, T. V., Van Zandt, M., . . . Hripcsak, G. M. (2025). The Role Of Drug Indication On Incidence Rate Heterogeneity: A Large-Scale, Systematic Evaluation Across An International Network Of Observational Databases.. medRxiv.
DOI |
| 2025 |
Widagdo, I., Kemp-Casey, A., Dorj, G., Andrade, A., & Pratt, N. (2025). Denominator Matters: Comparing the Impact of Estimated Resident Population Versus Medicare Enrolment Population on Healthcare Utilisation Analyses. Health Promotion Journal of Australia, 36(3), e70069.
DOI Scopus1 |
| 2025 |
Peng, K., Yang, D., Wang, J., Shen, C. Y., Cheng, M. C. Y., Chan, S. C. W., . . . Li, X. (2025). Predicting infection risk in Rheumatoid Arthritis patients treated with biological and targeted synthetic disease-modifying anti-Rheumatic drugs: an application of machine learning. Studies in Health Technology and Informatics, 329, 1900-1901.
DOI |
| 2025 |
Ghadirinejad, K., Graves, S., de Steiger, R., Pratt, N., Solomon, L. B., Taylor, M., & Hashemi, R. (2025). Can a machine learning approach contribute to monitoring post-market surveillance of total knee arthroplasty prostheses?. Knee, 58, S0968-0160(25)00272-8.
DOI |
| 2025 |
Janetzki, J., Johnson, J., Kalisch Ellett, L., Ho, J. N., Hall, K., Ward, M., & Pratt, N. (2025). Effect and illustrative costs of downscheduling on government subsidised dispensings of triptans in Australia: a 10-year analysis. Australian Health Review, 49(4, article no. AH25050), 1-7.
DOI |
| 2025 |
Janetzki, J., Kalisch, L., Hall, K., & Pratt, N. (2025). Utilisation trends of lisdexamfetamine: insights from recent medicine shortages in Australia. Pharmacoepidemiology and Drug Safety, 34(2, article no. e70113), 1-6.
DOI Scopus1 WoS1 Europe PMC1 |
| 2025 |
Janetzki, J. L., Kim, J. H., Minty, E., Lee, J. A., Morales, D. R., Khera, R., . . . Chan You, S. (2025). Risk of aortic aneurysm or dissection following use of fluoroquinolones: a retrospective multinational network cohort study. Eclinicalmedicine, 81(103096), 11 pages.
DOI Scopus4 WoS2 Europe PMC2 |
| 2025 |
Kalisch Ellett, L. M., Janetzki, J. L., Lim, R., Laba, T. L., & Pratt, N. L. (2025). Innovations in pharmacovigilance studies of medicines in older people. British Journal of Clinical Pharmacology, 91(1), 66-83.
DOI Scopus1 WoS2 Europe PMC2 |
| 2025 |
Cheung, E. C. L., Wang, Y., Ellett, L. K., Adesuyan, M., Szilcz, M., Shah, S., . . . Chui, C. S. L. (2025). Prescribing trends and time series analysis of blood pressure-lowering drugs among patients with dementia: a multinational database study. ECLINICALMEDICINE, 90(103595), 11 pages.
DOI |
| 2025 |
Hillen, J. B., Stanford, T., Ward, M., Duszynski, K., Tong, X., Li, S. X., . . . Pratt, N. (2025). Medicines Policy in Action: The Impact on Volume and Cost of Biologic Medicines After Biosimilar Introduction. Value in Health Regional Issues, 50(101173), 7 pages.
DOI |
| 2025 |
Cheung, E. C. L., Adesuyan, M., Szilcz, M., Kalisch Ellett, L. M., Shah, S., Jani, Y. H., . . . Chui, C. S. L. (2025). Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study. Age and Ageing, 54(5), 12 pages.
DOI Scopus2 WoS2 Europe PMC2 |
| 2025 |
Luong, C. -H. L., Kalisch Ellett, L., Costa, J. D. O., Chidwick, K., Pratt, N., & Janetzki, J. (2025). Impact of antiretroviral shortages in HIV therapy and prevention uptake in Australia.. AIDS care, 1-11.
DOI |
| 2025 |
Azroun, R., Ellett, L. K., Pratt, N., Ward, M., & Janetzki, J. (2025). National Response to Warfarin Shortages: evaluating Regulatory Substitution and Notified Shortages and Their Effects on Antithrombotic Dispensings, Pathology Monitoring and Adverse Event Trends in Australia. Drug Safety, online, 11 pages.
DOI |
| 2025 |
Luong, C. H. L., Kalisch Ellett, L., Pratt, N., Staff, K., & Janetzki, J. (2025). Trends in Use of Direct-Acting Antivirals for Treatment of Hepatitis C Virus Infection in Australia 2016-2024. Journal of Viral Hepatitis, 32(10, article no. e70082), 1-7.
DOI Europe PMC1 |
| 2025 |
Norén, G. N., Donegan, K., Muñoz, M. A., Alshammari, T. M., Pratt, N., Candore, G., . . . Ryan, P. B. (2025). Recommendations to Enable Broader Use of Real-World Evidence to Inform Decision-Making Throughout Pharmacovigilance Signal Management. Pharmacoepidemiology and Drug Safety, 34(10), 15 pages.
DOI |
| 2025 |
Haber, R., Webster-Clark, M., Pratt, N., Barclay, N., Li, X., Maro, J. C., . . . Filion, K. B. (2025). Core Concepts in Pharmacoepidemiology: Multi-Database Distributed Data Networks. Pharmacoepidemiology and Drug Safety, 34(7), 11 pages.
DOI Scopus1 WoS1 Europe PMC2 |
| 2025 |
Dávila-García, D. M., Falconer, T., Pratt, N., Natarajan, K., & Hripcsak, G. (2025). Heterogeneity of treatment effects of glucose-lowering drug classes for type 2 diabetes: LEGEND-T2DM network real-world evidence. Journal of Diabetes and Its Complications, 39(9), 8 pages.
DOI |
| 2025 |
Ho, J. N., Hillen, J. B., Daniels, B., Lim, R., & Pratt, N. (2025). Systematic Evaluation of Australian Risk Management Plans for Biologic Medicines. Drug Safety, 48(9), 1063-1072.
DOI |
| 2025 |
Widagdo, I., Kerr, M., Ellett, L. K., Schlegel, C., Sadeqzadeh, E., Wang, A., . . . Pratt, N. (2025). Validity of the Updated Rx-Risk Index as a Disease Identification and Risk-Adjustment Tool for Use in Observational Health Studies. Clinical Interventions in Aging, 20, 309-323.
DOI |
| 2024 |
Convertino, I., Lopes, L. C., Pratt, N., Ingrasciotta, Y., & Tuccori, M. (2024). Editorial: Biologic drugs in immune-mediated inflammatory diseases, validation, drug-utilization, effectiveness, regulation, costs, and safety in the real-world. Frontiers in Pharmacology, 15, 3 pages.
DOI Scopus1 WoS1 Europe PMC1 |
| 2024 |
Khera, R., Aminorroaya, A., Dhingra, L. S., Thangaraj, P. M., Pedroso Camargos, A., Bu, F., . . . Suchard, M. A. (2024). Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM. Journal of the American College of Cardiology, 84(10), 904-917.
DOI Scopus16 WoS14 Europe PMC14 |
| 2024 |
Stehlik, P., Dowsett, C., Camacho, X., Falster, M. O., Lim, R., Nasreen, S., . . . Henry, D. (2024). Evolution of the data and methods in real-world COVID-19 vaccine effectiveness studies on mortality: a scoping review protocol. BMJ Open, 14(3, article no. e079071), 1-5.
DOI Scopus2 WoS2 Europe PMC2 |
| 2024 |
Hallinan, C. M., Ward, R., Hart, G. K., Sullivan, C., Pratt, N., Ng, A. P., . . . Boyle, D. (2024). Seamless EMR data access: Integrated governance, digital health and the OMOP-CDM. BMJ Health and Care Informatics, 31(1), 7 pages.
DOI Scopus18 WoS17 Europe PMC20 |
| 2024 |
Camacho, X., Schaffer, A. L., Brett, J., Pratt, N., Buckley, N. A., Henry, D., & Pearson, S. A. (2024). Quality use of publicly subsidised tapentadol in Australia: a population-based analysis. Internal Medicine Journal, 54(6), 941-950.
DOI Scopus2 WoS1 Europe PMC2 |
| 2024 |
Janetzki, J., Sykes, M., Ward, M., & Pratt, N. (2024). Chronic Obstructive Pulmonary Disease adverse event signals associated with potential inhibitors of glutathione peroxidase 1: a sequence symmetry analysis. Drug Safety, 47(1), 59-70.
DOI Scopus1 |
| 2024 |
Huxley, N., Sidhu, V., Kelly, T. L., Pratt, N. L., Graves, S. E., Buchbinder, R., . . . Harris, A. (2024). Cost-effectiveness of enoxaparin versus aspirin in the prevention of venous thromboembolism after total hip or knee arthroplasty: an analysis from the CRISTAL cluster-randomized trial. Bone and Joint Journal, 106-B(6), 589-595.
DOI Scopus6 WoS5 Europe PMC5 |
| 2024 |
Gillies, M. B., Bharat, C., Camacho, X., Daniels, B., Hall, K., Kelly, T. L., . . . Pratt, N. (2024). Medicine utilization studies in Australian individual-level dispensing data: a blinded, multi-center replicated analysis. Pharmacoepidemiology and drug safety, 33(3, article no. e5776), 1-10.
DOI Scopus1 WoS1 Europe PMC1 |
| 2024 |
Kelly, T. -L., Salter, A., & Pratt, N. L. (2024). The weighted cumulative exposure method and its application to pharmacoepidemiology: A narrative review. Pharmacoepidemiology and Drug Safety, 33(1), e5701-1-e5701-9.
DOI Scopus7 WoS7 Europe PMC7 |
| 2024 |
Ghadirinejad, K., Graves, S., de Steiger, R., Pratt, N., Solomon, L. B., Taylor, M., & Hashem, R. (2024). What is the most appropriate comparator group to use in assessing the performance of primary total hip prostheses within the community?. HIP International, 34(3), 320-326.
DOI |
| 2024 |
Ghadirinejad, K., Graves, S., de Steiger, R., Pratt, N., Solomon, L. B., Taylor, M., & Hashemi, R. (2024). What Is the most appropriate comparator to use in assessing the comparative performance of primary total knee prostheses? a registry-based study. Arthroplasty Today, 27(101344), 1-7.
DOI |
| 2024 |
Ghadirinejad, K., Milimonfared, R., Taylor, M., Solomon, L. B., Graves, S., Pratt, N., . . . Hashemi, R. (2024). Supervised machine learning for the prediction of post-operative clinical outcomes of hip and knee replacements: a review. ANZ Journal of Surgery, 94(7-8), 1228-1233.
DOI |
| 2024 |
Sidhu, V., Kelly, T. L., Pratt, N., Graves, S. E., Cashman, K., & Harris, I. A. (2024). Aspirin or enoxaparin for VTE prophylaxis after primary partial, total or revision hip or knee arthroplasty: a secondary analysis from the CRISTAL cluster randomized trial. PLoS ONE, 19(4 April), 1-13.
DOI Scopus4 WoS1 Europe PMC2 |
| 2024 |
Ghadirinejad, K., Graves, S., de Steiger, R., Pratt, N., Solomon, L. B., Taylor, M., & Hashemi, R. (2024). Can Machine Learning Algorithms Contribute to the Initial Screening of Hip Prostheses and Early Identification of Outliers?. Prosthesis, 6(4), 744-752.
DOI Scopus1 WoS1 |
| 2023 |
Moffat, A. K., Apajee, J., Le Blanc, V. T., Westaway, K., Andrade, A. Q., Ramsay, E. N., . . . Roughead, E. E. (2023). Reducing opioid use for chronic non-cancer pain in primary care using an evidence-based, theory-informed, multistrategic, multistakeholder approach: A single-arm time series with segmented regression. BMJ Quality and Safety, 32(11), 623-631.
DOI Scopus4 WoS5 Europe PMC6 |
| 2023 |
Andrade, A. Q., Calabretto, J. -P., Pratt, N., Kalisch-Ellett, L., LeBlanc, V. T., & Roughead, E. E. (2023). Precision public health intervention for care coordination: A real world study. British Journal of General Practice, 73(728), e220-1-e220-11.
DOI Scopus1 Europe PMC1 |
| 2023 |
Kelly, T. L., & Pratt, N. (2023). Effect of aspirin vs enoxaparin on 90-day mortality in patients undergoing hip or knee arthroplasty: a secondary analysis of the CRISTAL cluster randomized trial. JAMA Network Open, 6(6, article no. e2317838), 1-11.
DOI Scopus8 WoS4 Europe PMC5 |
| 2023 |
Peng, K., Blais, J. E., Pratt, N. L., Guo, J. J., Hillen, J. B., Stanford, T., . . . Li, X. (2023). Impact of introducing infliximab biosimilars on total infliximab consumption and originator infliximab prices in eight regions: an interrupted time-series analysis. BioDrugs, 37(3), 409-420.
DOI Scopus10 WoS11 Europe PMC6 |
| 2023 |
Andrade, A. Q., Widagdo, I., Lim, R., Kelly, T. L., Parfitt, G., Pratt, N., . . . Roughead, E. E. (2023). Correlation of frailty assessment metrics in one-year follow-up of aged care residents: a sub-study of a randomised controlled trial. Aging Clinical and Experimental Research, 35(10), 2081-2087.
DOI Scopus1 WoS1 |
| 2023 |
Kalisch Ellett, L. M., Dorj, G., Andrade, A. Q., Bilton, R. L., Rowett, D., Whitehouse, J., . . . Roughead, E. E. (2023). Prevalence and preventability of adverse medicine events in a sample of Australian aged-care residents: a secondary analysis of data from the ReMInDAR trial. Drug Safety, 46(5), 493-500.
DOI Scopus4 WoS3 Europe PMC3 |
| 2023 |
Dorj, G., Nair, N. P., Bereznicki, L., Kelly, T. L., Pratt, N., Kalisch-Ellett, L., . . . Roughead, E. (2023). Correction to: Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial (Drugs & Aging, (2023), 40, 1, (49-58), 10.1007/s40266-022-00983-6). Drugs and Aging, 40(1), 89.
DOI |
| 2023 |
Dorj, G., Nair, N. P., Bereznicki, L., Thu Kelly, L., Pratt, N., Kalisch Ellet, L., . . . Roughead, E. (2023). Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial. Drugs & Aging, 40(1), 49-58.
DOI Scopus7 WoS8 Europe PMC5 |
| 2023 |
Andrade, A. Q., Lim, R., Kelly, T. L., Parfitt, G., Pratt, N., & Roughead, E. E. (2023). Wrist accelerometer temporal analysis as a prognostic tool for aged care residents: A sub-study of the ReMInDAR trial. Journal of the American Geriatrics Society, 71(4), 1124-1133.
DOI Scopus2 WoS3 Europe PMC4 |
| 2023 |
You, S. C., Seo, S. I., Falconer, T., Yanover, C., Duarte-Salles, T., Seager, S., . . . Prieto-Alhambra, D. (2023). Ranitidine Use and Incident Cancer in a Multinational Cohort. JAMA Network Open, 6(9), 14 pages.
DOI Scopus12 WoS12 Europe PMC9 |
| 2023 |
Janetzki, J. L., Pratt, N. L., Ward, M. B., & Sykes, M. J. (2023). Application of an integrative drug safety model for detection of adverse drug events associated with inhibition of glutathione peroxidase 1 in chronic obstructive pulmonary disease. Pharmaceutical Research, 40(6), 1553-1568.
DOI Scopus3 WoS2 Europe PMC3 |
| 2023 |
Lund, L. C., Jensen, P. H., Pottegård, A., Andersen, M., Pratt, N., & Hallas, J. (2023). Identifying diabetogenic drugs using real world health care databases: A Danish and Australian symmetry analysis. Diabetes Obesity and Metabolism, 25(5), 1311-1320.
DOI Scopus11 WoS9 Europe PMC8 |
| 2023 |
Liu, B., Stepien, S., Dobbins, T., Gidding, H., Henry, D., Korda, R., . . . Macartney, K. (2023). Effectiveness of COVID-19 vaccination against COVID-19 specific and all-cause mortality in older Australians: a population based study. Lancet Regional Health Western Pacific, 40(100928), 13 pages.
DOI Scopus25 WoS19 Europe PMC17 |
| 2023 |
Khera, R., Dhingra, L. S., Aminorroaya, A., Li, K., Zhou, J. J., Arshad, F., . . . Suchard, M. A. (2023). Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM. BMJ MEDICINE, 2(1), 12 pages.
DOI WoS16 Europe PMC19 |
| 2023 |
Tong, X., Shen, C. Y., Jeon, H. L., Li, Y., Shin, J. Y., Chan, S. C. W., . . . Lai, E. C. C. (2023). Cardiovascular risk in rheumatoid arthritis patients treated with targeted synthetic and biological disease-modifying antirheumatic drugs: a multi-centre cohort study. Journal Of Internal Medicine, 294(3), 314-325.
DOI Scopus17 WoS18 Europe PMC18 |
| 2023 |
Lim, R., Dumuid, D., Parfitt, G., Stanford, T., Post, D., Bilton, R., . . . Roughead, E. E. (2023). Using wrist-worn accelerometers to identify the impact of medicines with anticholinergic or sedative properties on sedentary time: A 12-month prospective analysis. Maturitas, 172, 9-14.
DOI Scopus7 WoS7 Europe PMC5 |
| 2023 |
Ostropolets, A., Albogami, Y., Conover, M., Banda, J. M., Baumgartner, W. A., Blacketer, C., . . . Ryan, P. B. (2023). Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational study. Journal of the American Medical Informatics Association, 30(5), 859-868.
DOI Scopus9 WoS7 Europe PMC11 |
| 2023 |
Wang, S. V., Pottegård, A., Crown, W., Arlett, P., Ashcroft, D. M., Benchimol, E. I., . . . Williams, R. J. (2023). HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force. Pharmacoepidemiology and Drug Safety, 32(1), 44-55.
DOI Scopus63 WoS48 Europe PMC55 |
| 2023 |
de Steiger, R. N., Pratt, N. L., Gulyani, A., Duszynski, K. M., Inacio, M. C., Graves, S. E., & Smith, P. N. (2023). Antibiotic utilisation in primary and revision total hip replacement patients: a registry linkage cohort study of 106 253 patients using the Australian Orthopaedic Association National Joint Replacement Registry. Pharmacoepidemiology and Drug Safety, 32(2), 238-247.
DOI Scopus3 WoS3 Europe PMC3 |
| 2022 |
Hillen, J. B., Stanford, T., Ward, M., Roughead, E. E., Kalisch-Ellett, L., & Pratt, N. (2022). Rituximab and Pyoderma Gangrenosum: An Investigation of Disproportionality Using a Systems Biology-Informed Approach in the FAERS Database. Drugs Real World Outcomes, 9(4), 639-647.
DOI Scopus3 WoS2 Europe PMC3 |
| 2022 |
de Oliveira Costa, J., Pearson, S. A., Donnolley, N., Bailey, B., Hollingworth, S., Stanford, T., & Pratt, N. (2022). Parity in female authorship in Australian pharmacoepidemiology research leveraging medicine dispensing data: How well are we doing?. Pharmacoepidemiology and Drug Safety, 31(9), 1010-1012.
DOI Scopus1 WoS1 Europe PMC1 |
| 2022 |
Lu, Y., Van Zandt, M., Liu, Y., Li, J., Wang, X., Chen, Y., . . . Xu, H. (2022). Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort. JAMA Network Open, 5(3), E223877.
DOI Scopus17 WoS14 Europe PMC15 |
| 2022 |
Kassie, G. M., Roughead, E. E., Nguyen, T. A., Pratt, N. L., & Kalisch Ellett, L. M. (2022). The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study. Drug Safety, 45(1), 75-82.
DOI Scopus10 WoS10 Europe PMC10 |
| 2022 |
Jin, X., Gallego Luxan, B., Hanly, M., Pratt, N. L., Harris, I., de Steiger, R., . . . Jorm, L. (2022). Estimating incidence rates of periprosthetic joint infection after hip and knee arthroplasty for osteoarthritis using linked registry and administrative health data. The bone & joint journal, 104-B(9), 1060-1066.
DOI Scopus78 WoS69 Europe PMC65 |
| 2022 |
Tong, X., Li, X., Pratt, N. L., Hillen, J. B., Stanford, T., Ward, M., . . . Wong, I. C. K. (2022). Monoclonal antibodies and Fc-fusion protein biologic medicines: a multinational cross-sectional investigation of accessibility and affordability in Asia Pacific regions between 2010 and 2020. Lancet Regional Health-Western Pacific, 26(100506), 1-12.
DOI Scopus19 WoS16 Europe PMC14 |
| 2022 |
Williams, R. D., Markus, A. F., Yang, C., Duarte-Salles, T., DuVall, S. L., Falconer, T., . . . Rijnbeek, P. R. (2022). Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network. BMC Medical Research Methodology, 22(1), 13 pages.
DOI Scopus14 WoS15 Europe PMC27 |
| 2022 |
Wang, S. V., Pottegård, A., Crown, W., Arlett, P., Ashcroft, D. M., Benchimol, E. I., . . . Williams, R. J. (2022). HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force. Value in Health, 25(10), 1663-1672.
DOI Scopus41 WoS47 Europe PMC39 |
| 2022 |
Nishimura, A., Xie, J., Kostka, K., Duarte-Salles, T., Fernández Bertolín, S., Aragón, M., . . . Suchard, M. A. (2022). International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients. Frontiers in Pharmacology, 13(945592), 14 pages.
DOI Scopus5 WoS4 Europe PMC3 |
| 2022 |
Man, K. K. C., Shao, S. C., Chaiyakunapruk, N., Dilokthornsakul, P., Kubota, K., Li, J., . . . Lai, E. C. C. (2022). Metabolic events associated with the use of antipsychotics in children, adolescents and young adults: a multinational sequence symmetry study. European Child and Adolescent Psychiatry, 31(1), 99-120.
DOI Scopus10 WoS10 Europe PMC7 |
| 2022 |
Hillen, J., Ward, M., Slee, M., Stanford, T., Roughead, E., Kalisch Ellett, L., & Pratt, N. (2022). Utilisation of disease modifying treatment and diversity of treatment pathways in relapsing remitting multiple sclerosis. Multiple Sclerosis and Related Disorders, 57(article no. 103412), 8 pages.
DOI Scopus3 WoS3 Europe PMC3 |
| 2022 |
Pratt, N. L., Cicuttini, F. M., Wang, Y., & Graves, S. E. (2022). No increased risk of cancer associated with metal-on-metal or ceramic-on-ceramic procedures compared to other bearing surfaces in patients with total hip arthroplasty: a nationwide linked registry cohort analysis of 167,837 patients. PloS one, 17(11, article no. e0278241), 1-12.
DOI Scopus5 WoS6 Europe PMC4 |
| 2022 |
Roughead, E. E., Kerr, M., Moffat, A., Kassie, G. M., & Pratt, N. (2022). Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case–Control Study with a Focus on Medicines Used in Primary Care. Drug Safety, 45(11), 1413-1421.
DOI Scopus13 WoS11 Europe PMC11 |
| 2022 |
Schuemie, M. J., Arshad, F., Pratt, N., Nyberg, F., Alshammari, T. M., Hripcsak, G., . . . Suchard, M. A. (2022). Vaccine Safety Surveillance Using Routinely Collected Healthcare Data—An Empirical Evaluation of Epidemiological Designs. Frontiers in Pharmacology, 13(article no. 893484), 11 pages.
DOI Scopus11 WoS15 Europe PMC13 |
| 2022 |
Seo, M. S., Hillen, J., Kang, D. Y., Pratt, N., & Shin, J. Y. (2022). Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea. Frontiers in Pharmacology, 13(834116), 8 pages.
DOI Scopus4 WoS3 Europe PMC2 |
| 2022 |
Lai, L. Y. H., Arshad, F., Areia, C., Alshammari, T. M., Alghoul, H., Casajust, P., . . . Schuemie, M. J. (2022). Current Approaches to Vaccine Safety Using Observational Data: A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design. Frontiers in Pharmacology, 13, 11 pages.
DOI Scopus15 WoS14 Europe PMC14 |
| 2022 |
Dorj, G., Lim, R., Ellett, L. K., Kelly, T. L., Andrade, A., Widagdo, I., . . . Roughead, E. (2022). Medicine-related problems: a recurrent issue among residents living in nursing homes. Frontiers In Pharmacology, 13, 1-9.
DOI Scopus1 WoS2 Europe PMC1 |
| 2022 |
Lim, R., Kelly, T. L., Andrade, A. Q., Kalisch Ellett, L. M., Bilton, R., Dorj, G., . . . Roughead, E. E. (2022). Frailty trajectory over one year among residential aged care (nursing home) residents. Frontiers In Medicine, 9(1010444), 1-8.
DOI Scopus4 WoS4 Europe PMC4 |
| 2022 |
Kelly, T. L., Ward, M., Pratt, N. L., Ramsay, E., Gillam, M., & Roughead, E. E. (2022). The association between exacerbation of chronic obstructive pulmonary disease and timing of paracetamol use: a cohort study in elderly Australians. Respiratory Research, 23(1), 11 pages.
DOI Scopus3 WoS3 Europe PMC3 |
| 2022 |
Roughead, E. E., Ramsay, E. N., Kalisch Ellett, L. M., Khoo, A., Moffatt, A., & Pratt, N. L. (2022). Variation in health service use by veterans with an accepted disability of post-traumatic stress disorder who had a service record post 1975: A cluster analysis. BMJ Military Health, 168(1), 76-81.
DOI Scopus1 WoS1 |
| 2022 |
Gillam, M. H., Pratt, N. L., Inacio, M. C. S., Shakib, S., Caughey, G. E., Sanders, P., . . . Roughead, E. E. (2022). Cardiac implantable electronic devices: reoperations and the competing risk of death. Heart Lung and Circulation, 31(4), 537-543.
DOI |
| 2022 |
Andrade, A. Q., Calabretto, J. -P., Pratt, N. L., Kalisch-Ellett, L. M., Kassie, G. M., LeBlanc, V. T., . . . Roughead, E. E. (2022). Implementation and Evaluation of a Digitally Enabled Precision Public Health Intervention to Reduce Inappropriate Gabapentinoid Prescription: Cluster Randomized Controlled Trial. Journal of Medical Internet Research, 24(1), e33873-1-e33873-12.
DOI Scopus5 WoS6 Europe PMC6 |
| 2022 |
Roughead, E. E., Pratt, N. L., Parfitt, G., Rowett, D., Kalisch-Ellett, L. M., Bereznicki, L., . . . Lim, R. (2022). Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial). AGE AND AGEING, 51(4), 1-9.
DOI Scopus25 WoS21 Europe PMC25 |
| 2022 |
Cuthbert, A. R., Giles, L. C., Glonek, G., Ellett, L. M. K., & Pratt, N. L. (2022). A comparison of survival models for prediction of eight-year revision risk following total knee and hip arthroplasty. BMC Medical Research Methodology, 22(1), 164-1-164-13.
DOI Scopus9 WoS8 Europe PMC6 |
| 2022 |
Sidhu, V. S., Kelly, T. L., Pratt, N., Graves, S. E., & Harris, I. A. (2022). Effect of aspirin vs enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: the CRISTAL randomized trial. JAMA, 328(8), 719-727.
DOI Scopus142 WoS135 Europe PMC109 |
| 2022 |
Schuemie, M. J., Arshad, F., Pratt, N., Nyberg, F., Alshammari, T. M., Hripcsak, G., . . . Suchard, M. A. (2022). Corrigendum: Vaccine safety surveillance using routinely collected healthcare data—An empirical evaluation of epidemiological designs(Front. Pharmacol., (2022), 13, (893484), 10.3389/fphar.2022.893484). Frontiers in Pharmacology, 13, 3 pages.
DOI Scopus5 |
| 2021 |
Pratt, N., Camacho, X., Vajdic, C., Degenhardt, L., Laba, T. L., Hillen, J., . . . Pearson, S. A. (2021). The Medicines Intelligence Centre of Research Excellence: Co-creating real-world evidence to support the evidentiary needs of Australian medicines regulators and payers. International Journal of Population Data Science, 6(3), 1726.
DOI Scopus3 Europe PMC3 |
| 2021 |
Cuthbert, A. R., Graves, S. E., Giles, L. C., Glonek, G., & Pratt, N. (2021). What Is the Effect of Using a Competing-risks Estimator when Predicting Survivorship After Joint Arthroplasty: A Comparison of Approaches to Survivorship Estimation in a Large Registry. Clinical orthopaedics and related research, 479(2), 392-403.
DOI Scopus6 WoS7 Europe PMC8 |
| 2021 |
Kalisch Ellett, L. M., Kassie, G. M., Ramsay, E. N., Pratt, N. L., & Roughead, E. E. (2021). Evaluation of Renal Function Testing in Older Australian Veterans Dispensed Medicines that Require Renal Function Monitoring. Drugs and Aging, 38(11), 995-1002.
DOI Scopus1 WoS1 Europe PMC1 |
| 2021 |
Park, S. H., Jeon, H. L., Kim, S. C., Hillen, J., Gadzhanova, S., Shin, J. Y., & Pratt, N. (2021). Utilization of targeted disease-modifying anti-rheumatic drugs (DMARDs) for managing rheumatoid arthritis in the last decade: A two-country comparison. International Journal of Clinical Pharmacology and Therapeutics, 59(10), 639-644.
DOI Scopus2 WoS2 Europe PMC2 |
| 2021 |
Kubota, K., Kelly, T. L., Sato, T., Pratt, N., Roughead, E., & Yamaguchi, T. (2021). A novel weighting method to remove bias from within-subject exposure dependency in case-crossover studies. BMC Medical Research Methodology, 21(1, article no. 214), 1-13.
DOI Scopus10 WoS10 Europe PMC9 |
| 2021 |
Sidhu, V. S., Kelly, T. L., Pratt, N., Graves, S., Buchbinder, R., Naylor, J., . . . Harris, I. (2021). CRISTAL (a cluster-randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study): statistical analysis plan. Trials, 22(1, article no. 564), 1-14.
DOI Scopus7 WoS6 Europe PMC5 |
| 2021 |
Kalisch Ellett, L. M., Kassie, G. M., Caughey, G. E., Pratt, N. L., Ramsay, E. N., & Roughead, E. E. (2021). Medication-related hospital admissions in aged care residents. Australasian journal on ageing, 40(4), e323-e331.
DOI Scopus10 WoS10 Europe PMC10 |
| 2021 |
Leach, M. J., Roughead, E. E., & Pratt, N. L. (2021). A data visualisation method for assessing exposure misclassification in case-crossover studies: the example of tricyclic antidepressants and the risk of hip fracture in older people. BMC Medical Research Methodology, 21(1, article no. 43, pp. 1-7), 7 pages.
DOI Scopus3 WoS2 Europe PMC2 |
| 2021 |
Reps, J. M., Rijnbeek, P., Cuthbert, A., Ryan, P. B., Pratt, N., & Schuemie, M. (2021). An empirical analysis of dealing with patients who are lost to follow-up when developing prognostic models using a cohort design. BMC Medical Informatics and Decision Making, 21(1), 24 pages.
DOI Scopus10 WoS10 Europe PMC8 |
| 2021 |
Chen, R. J., Suchard, M. A., Krumholz, H. M., Schuemie, M. J., Shea, S., Duke, J., . . . Hripcsak, G. (2021). Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study. Hypertension, 78(3), 591-603.
DOI Scopus127 WoS114 Europe PMC100 |
| 2021 |
You, S. C., Krumholz, H. M., Suchard, M. A., Schuemie, M. J., Hripcsak, G., Chen, R. J., . . . Park, S. (2021). Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational Study. Hypertension, 77(5), 1528-1538.
DOI Scopus26 WoS22 Europe PMC21 |
| 2021 |
Pearson, S. A., Pratt, N., Costa, J. D. O., Zoega, H., Laba, T. L., Etherton-Beer, C., . . . Henry, D. (2021). Generating real-world evidence on the quality use, benefits and safety of medicines in australia: History, challenges and a roadmap for the future. International Journal of Environmental Research and Public Health, 18(24), 20 pages.
DOI Scopus18 WoS15 Europe PMC13 |
| 2021 |
Duszynski, K. M., Stark, J. H., Cohet, C., Huang, W. T., Shin, J. Y., Lai, E. C. C., . . . Pratt, N. L. (2021). Suitability of databases in the Asia-Pacific for collaborative monitoring of vaccine safety. Pharmacoepidemiology and Drug Safety, 30(7), 843-857.
DOI Scopus9 WoS7 Europe PMC5 |
| 2021 |
Morales, D. R., Conover, M. M., You, S. C., Pratt, N., Kostka, K., Duarte-Salles, T., . . . Suchard, M. A. (2021). Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis. Lancet Digital Health, 3(2), e98-e114.
DOI Scopus87 WoS86 Europe PMC92 |
| 2021 |
Schuemie, M. J., Ryan, P. B., Pratt, N., Chen, R. J., You, S. C., Krumholz, H. M., . . . Suchard, M. A. (2021). Erratum: Large-Scale Evidence Generation and Evaluation across a Network of Databases (LEGEND): Assessing Validity Using Hypertension as a Case Study (Journal of the American Medical Informatics Association (2020) 27:8 (1268-1277) DOI: 10.1093/jamia/ocaa124). Journal of the American Medical Informatics Association, 28(1), 196.
DOI |
| 2021 |
Pratt, N., Camacho, X., Vajdic, C., Degenhardt, L., Laba, T. L., Hillen, J., . . . Pearson, S. A. (2021). The Medicines Intelligence Centre of Research Excellence: Co-creating real-world evidence to support the evidentiary needs of Australian regulators and payers. International Journal of Population Data Science, 6(3), 12 pages.
DOI WoS3 |
| 2021 |
Li, X., Lai, L. Y. H., Ostropolets, A., Arshad, F., Tan, E. H., Casajust, P., . . . Prieto-Alhambra, D. (2021). Bias, Precision and Timeliness of Historical (Background) Rate Comparison Methods for Vaccine Safety Monitoring: An Empirical Multi-Database Analysis. Frontiers in Pharmacology, 12(773875), 9 pages.
DOI Scopus10 WoS11 Europe PMC12 |
| 2021 |
Kerr, M., Graves, S., Duszynski, K., Inacio, M., de Steiger, R., Harris, I., . . . Pratt, N. (2021). Does a prescription-based comorbidity index correlate with the American Society of Anesthesiologists physical status score and mortality after joint arthroplasty? A registry study. Clinical Orthopaedics and Related Research, 479(10), 2181-2190.
DOI Scopus4 WoS3 Europe PMC4 |
| 2021 |
Hallas, J., Whitaker, H., Delaney, J. A., Cadarette, S. M., Pratt, N., & Maclure, M. (2021). The Use of Active Comparators in Self-Controlled Designs. American Journal of Epidemiology, 190(10), 2181-2187.
DOI Scopus24 WoS22 Europe PMC21 |
| 2021 |
Pratt, N. L., Ellett, L. M. K., Andrade, A. Q., Le Blanc, V. T., Barratt, J., & Roughead, E. E. (2021). Prevalence of multiple risk factors for poor outcomes associated with COVID-19 among an elderly Australian population. Australian Journal of General Practice, 50(1-2), 84-89.
DOI Scopus4 WoS3 Europe PMC3 |
| 2020 |
Schuemie, M. J., Ryan, P. B., Pratt, N., Chen, R. J., You, S. C., Krumholz, H. M., . . . Suchard, M. A. (2020). Principles of Large-scale Evidence Generation and Evaluation across a Network of Databases (LEGEND). Journal of the American Medical Informatics Association, 27(8), 1331-1337.
DOI Scopus33 WoS29 Europe PMC36 |
| 2020 |
Schuemie, M. J., Ryan, P. B., Pratt, N., Chen, R. J., You, S. C., Krumholz, H. M., . . . Suchard, M. A. (2020). Large-scale evidence generation and evaluation across a network of databases (LEGEND): assessing validity using hypertension as a case study. Journal of the American Medical Informatics Association, 27(8), 1268-1277.
DOI Scopus20 WoS18 Europe PMC21 |
| 2020 |
Jeon, H. L., Byun, S. J., Byun, S. J., Pratt, N. L., Sultana, J., Park, S. J., & Shin, J. Y. (2020). Cardiovascular risk in patients receiving ranibizumab for exudative age-related macular degeneration: a nationwide self-controlled case-series study. British Journal of Ophthalmology, 105(4), 542-548.
DOI Scopus10 WoS9 Europe PMC6 |
| 2020 |
Kalisch Ellett, L. M., Pratt, N. L., Nguyen, T. A., & Roughead, E. E. (2020). Use of health and support services by people living with dementia in the community setting. Australasian Journal on Ageing, 39(4), 341-349.
DOI Scopus4 WoS5 Europe PMC2 |
| 2020 |
Hripcsak, G., Suchard, M. A., Shea, S., Chen, R., You, S. C., Pratt, N., . . . Schuemie, M. J. (2020). Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension. JAMA Internal Medicine, 180(4), 542-551.
DOI Scopus122 WoS107 Europe PMC86 |
| 2020 |
Moffat, A. K., Apajee, J., Pratt, N. L., Blacker, N., Le, B. V. T., & Roughead, E. E. (2020). Use of medicines associated with dry mouth and dental visits in an Australian cohort. Australian Dental Journal, 65(3), 189-195.
DOI Scopus4 WoS4 Europe PMC3 |
| 2020 |
Moffat, A. K., Pratt, N. L., Kerr, M., Ellett, L. M. K., & Roughead, E. E. (2020). Risk of chronic opioid use in older persons with pre-existing anxiety. Journal of Opioid Management, 16(1), 59-66.
DOI Scopus3 Europe PMC3 |
| 2020 |
Pratt, N. L., Mack, C. D., Meyer, A. M., Davis, K. J., Hamill, B. G., Hampp, C., . . . Lund, J. L. (2020). Data linkage in pharmacoepidemiology: a call for rigorous evaluation and reporting. Pharmacoepidemiology and Drug Safety, 29(1), 9-17.
DOI Scopus32 WoS29 Europe PMC30 |
| 2020 |
King, C. E., Pratt, N. L., Craig, N., Thai, L., Wilson, M., Nandapalan, N., . . . Behm, E. C. (2020). Detecting medicine safety signals using prescription sequence symmetry analysis of a National Prescribing Data Set. Drug Safety, 43(8), 787-795.
DOI Scopus13 WoS14 Europe PMC13 |
| 2020 |
Andrade, A. Q., LeBlanc, V. T., Kalisch Ellett, L. M., Pratt, N. L., Moffat, A., Blacker, N., . . . Roughead, E. E. (2020). Determinants of usefulness in professional behaviour change interventions: observational study of a 15-year national program. BMJ open, 10(10), 1-8.
DOI Scopus3 WoS4 Europe PMC3 |
| 2020 |
Kalisch Ellett, L. M., Kemp-Casey, A., Kassie, G. M., Pratt, N. L., & Roughead, E. E. (2020). Use of analgesics following rescheduling of codeine in Australia: An interrupted time series analysis in the veteran population. International Journal of Drug Policy, 81, 7 pages.
DOI Scopus7 WoS7 Europe PMC4 |
| 2020 |
Baek, Y. H., Lee, H., Kim, W. J., Chung, J. E., Pratt, N., Kalisch Ellett, L., & Shin, J. Y. (2020). Uncertain Association Between Benzodiazepine Use and the Risk of Dementia: A Cohort Study. Journal of the American Medical Directors Association, 21(2), 201-211.e2.
DOI Scopus26 WoS26 Europe PMC19 |
| 2020 |
Brauer, R., Wong, I. C. K., Man, K. K. C., Pratt, N. L., Park, R. W., Cho, S. Y., . . . Schuemie, M. (2020). Application of a Common Data Model (CDM) to rank the paediatric user and prescription prevalence of 15 different drug classes in South Korea, Hong Kong, Taiwan, Japan and Australia: an observational, descriptive study. BMJ open, 10(1), 1-15.
DOI Scopus7 WoS5 Europe PMC4 |
| 2020 |
Moffat, A. K., Pratt, N. L., Ellett, L. M. K., Ramsay, E. N., & Roughead, E. E. (2020). Comorbidities in an Australian sample of chronic and new opioid users. Journal of Opioid Management, 16(2), 103-110.
DOI Scopus1 Europe PMC1 |
| 2020 |
Zhan, C., Roughead, E., Liu, L., Pratt, N., & Li, J. (2020). Detecting high-quality signals of adverse drug-drug interactions from spontaneous reporting data. Journal of Biomedical Informatics, 112(article no. 103603), 13 pages.
DOI Scopus14 WoS12 Europe PMC9 |
| 2020 |
Zhan, C., Roughead, E., Liu, L., Pratt, N., & Li, J. (2020). Detecting potential signals of adverse drug events from prescription data. Artificial Intelligence in Medicine, 104(101839), 14 pages.
DOI Scopus11 WoS9 Europe PMC9 |
| 2020 |
Moffat, A. K., Westaway, K. P., Apajee, J., Frank, O., Shute, R., Weston, C., . . . Roughead, E. E. (2020). Impact of a patient-specific national programme aimed at increasing the use of emollient moisturisers to reduce the risk of skin tears: a longitudinal cohort study.. BMJ open, 10(10), e039579.
DOI WoS1 Europe PMC1 |
| 2020 |
Lim, R., Bereznicki, L., Corlis, M., Kalisch Ellett, L. M., Kang, A. C., Merlin, T., . . . Roughead, E. E. (2020). Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome.. BMJ Open, 10(4), e032851.
DOI Scopus12 WoS12 Europe PMC11 |
| 2020 |
Marshall, H. S., Koehler, A. P., Wang, B., A'Houre, M., Gold, M., Quinn, H., . . . Macartney, K. (2020). Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia. Vaccine, 38(37), 5914-5922.
DOI Scopus17 WoS13 Europe PMC10 |
| 2019 |
Pratt, N. L., Ramsay, E., Kalisch Ellett, L. M., Duszynski, K., Shakib, S., Kerr, M., . . . Roughead, E. E. (2019). Comparative effectiveness and safety of low-strength and high-strength direct oral anticoagulants compared with warfarin: a sequential cohort study. BMJ Open, 9(5), e026486.
DOI Scopus9 WoS9 Europe PMC7 |
| 2019 |
Westaway, K., Blacker, N., Shute, R., Allin, R., Elgebaly, Z., Frank, O., . . . Roughead, E. (2019). Combination psychotropic medicine use in older adults and risk of hip fracture. Australian Prescriber, 42(3), 93-96.
DOI Scopus9 WoS8 Europe PMC7 |
| 2019 |
Harris, I. A., Hatton, A., Pratt, N., Lorimer, M., Naylor, J. M., De Steiger, R., . . . Graves, S. E. (2019). How does mortality risk change over time after hip and knee arthroplasty?. Clinical Orthopaedics and Related Research, 477(6), 1414-1421.
DOI Scopus17 WoS15 Europe PMC14 |
| 2019 |
Duszynski, K. M., Pratt, N. L., Lynch, J. W., Braunack-Mayer, A., Taylor, L. K., Berry, J. G., . . . Gold, M. S. (2019). Process trumps potential public good: better vaccine safety through linked cross-jurisdictional immunisation data in Australia. Australian and New Zealand Journal of Public Health, 43(5), 496-503.
DOI Scopus11 WoS10 Europe PMC7 |
| 2019 |
Sidhu, V. S., Graves, S. E., Buchbinder, R., Naylor, J. M., Pratt, N. L., de Steiger, R. S., . . . Harris, I. A. (2019). CRISTAL: protocol for a cluster randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study. BMJ open, 9(11, article no. e031657), 1-9.
DOI Scopus23 WoS22 Europe PMC19 |
| 2019 |
Roughead, E. E., Lim, R., Ramsay, E., Moffat, A., & Pratt, N. (2019). Persistence with opioids post discharge from hospitalisation for surgery in Australian adults: a retrospective cohort study. BMJ open, 9(4, article no. e023990), 1-6.
DOI Scopus29 WoS30 Europe PMC22 |
| 2019 |
Kelly, T. L., & Pratt, N. (2019). A note on sample size calculations for cluster randomised crossover trials with a fixed number of clusters. Statistics in medicine, 38(18), 3342-3345.
DOI Scopus6 WoS5 Europe PMC5 |
| 2019 |
Lim, R., Kalisch Ellett, L. M., Widagdo, I. S., Pratt, N. L., & Roughead, E. E. (2019). Analysis of anticholinergic and sedative medicine effects on physical function, cognitive function, appetite and frailty: A cross-sectional study in Australia. BMJ Open, 9(9), 9 pages.
DOI Scopus33 WoS31 Europe PMC25 |
| 2019 |
Ellett, L. M. K., Kassie, G. M., Pratt, N. L., Kerr, M., & Roughead, E. E. (2019). Prevalence and Duration of Use of Medicines Recommended for Short-Term Use in Aged Care Facility Residents. PHARMACY, 7(2), 11 pages.
DOI WoS7 Europe PMC7 |
| 2019 |
Gillam, M. H., Kerr, M., Pratt, N. L., Lim, R., & Roughead, E. E. (2019). Mesh use in urogynaecological procedures between 2005 and 2016: an Australian cohort study. Australian and New Zealand journal of obstetrics and gynaecology, 59(1), 105-109.
DOI Scopus4 WoS4 Europe PMC3 |
| 2019 |
Suchard, M. A., Schuemie, M. J., Krumholz, H. M., You, S. C., Chen, R. J., Pratt, N., . . . Ryan, P. B. (2019). Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet, 394(10211), 1816-1826.
DOI Scopus260 WoS245 Europe PMC251 |
| 2019 |
Preiss, A. K., Roughead, E. E., & Pratt, N. L. (2019). Sequence symmetry analysis graphic adjustment for prescribing trends. BMC medical research methodology, 19(1, article no.143), 1-12.
DOI Scopus7 WoS6 Europe PMC6 |
| 2019 |
Kalisch Ellett, L. M., Pratt, N. L., Apajee, J., & Roughead, E. E. (2019). Initiation and continuation of antipsychotic medicines in older people following non-psychiatric hospital admission. International Journal of Clinical Pharmacy, 41(5), 1341-1347.
DOI Scopus6 WoS6 Europe PMC3 |
| 2019 |
Kemp-Casey, A., Pratt, N., Ramsay, E., & Roughead, E. E. (2019). Using post-market utilisation analysis to support medicines pricing policy: an Australian case study of aflibercept and ranibizumab use. Applied Health Economics and Health Policy, 17(3), 411-417.
DOI Scopus6 WoS6 Europe PMC5 |
| 2019 |
Rasmussen, L., Pratt, N., Roughead, E., & Moffat, A. (2019). Prevalence of psychotropic medicine use in Australian children with autism spectrum disorder: a drug utilization study based on children enrolled in the longitudinal study of Australian children. Journal of Autism and Developmental Disorders, 49(1), 227-235.
DOI Scopus14 WoS13 Europe PMC10 |
| 2019 |
Duszynski, K. M., Pratt, N. L., Lynch, J. W., Berry, J. G., & Gold, M. S. (2019). Use of different combination diphtheria-tetanus-acellular pertussis vaccines does not increase risk of 30-day infant mortality. A population-based linkage cohort study using administrative data from the Australian Childhood Immunisation Register and the National Death Index. Vaccine, 37(2), 280-288.
DOI Scopus3 WoS3 Europe PMC3 |
| 2019 |
Kalisch Ellett, L. M., Moffat, A. K., Gadzhanova, S., Pratt, N. L., Apajee, J., Woodward, M., & Roughead, E. E. (Eds.) (2019). Reduction in use of risperidone for dementia in Australia following changed guidelines. Pharmacy, 7(3), 1-11. |
| 2018 |
Park, S. K., Baek, Y. H., Pratt, N., Kalisch Ellett, L., & Shin, J. Y. (2018). The uncertainty of the association between proton pump inhibitor use and the risk of dementia: prescription sequence symmetry analysis using a Korean healthcare database between 2002 and 2013. Drug safety, 41(6), 615-624.
DOI Scopus28 WoS23 Europe PMC23 |
| 2018 |
Hallas, J., Wang, S. V., Gagne, J. J., Schneeweiss, S., Pratt, N., & Pottegård, A. (2018). Hypothesis-free screening of large administrative databases for unsuspected drug-outcome associations. European Journal of Epidemiology, 33(6), 545-555.
DOI Scopus36 WoS34 Europe PMC26 |
| 2018 |
Bartlett, L. E., Pratt, N., & Roughead, E. E. (2018). Does a fixed-dose combination of amlodipine and atorvastatin improve persistence with therapy in the Australian population?. Current Medical Research and Opinion, 34(2), 305-311.
DOI Scopus7 WoS7 Europe PMC7 |
| 2018 |
Kalisch Ellett, L. M., Pratt, N. L., Kerr, M., & Roughead, E. E. (2018). Antipsychotic polypharmacy in older Australians. International Psychogeriatrics, 30(4), 539-546.
DOI Scopus8 WoS9 Europe PMC6 |
| 2018 |
Kalisch Ellett, L. M., Lim, R., Pratt, N. L., Kerr, M., Ramsay, E. N., Leblanc, T. V., . . . Roughead, E. E. (2018). Reducing hypnotic use in insomnia management among Australian veterans: Results from repeated national interventions. BMC Health Services Research, 18(1), 626.
DOI Scopus4 WoS4 Europe PMC4 |
| 2018 |
Rasmussen, L., Pratt, N., Hansen, M. R., Hallas, J., & Pottegård, A. (2018). Using the 'proportion of patients covered' and the Kaplan-Meier survival analysis to describe treatment persistence. Pharmacoepidemiology and Drug Safety, 27(8), 867-871.
DOI Scopus45 WoS44 Europe PMC34 |
| 2018 |
Zhan, C., Roughead, E., Liu, L., Pratt, N., & Li, J. (2018). A data-driven method to detect adverse drug events from prescription data. Journal of Biomedical Informatics, 85, 10-20.
DOI Scopus9 WoS8 Europe PMC6 |
| 2018 |
Kalisch Ellett, L. M., Pratt, N. L., Sluggett, J. K., Ramsay, E. N., Kerr, M., LeBlanc, V. T., . . . Roughead, E. E. (2018). Sustaining practice change in health care: the impact of a national quality improvement program on the uptake of collaborative medicines reviews. Journal of pharmacy practice and research, 48(3), 222-230.
DOI Scopus7 |
| 2018 |
Bartlett, L. E., Pratt, N. L., & Roughead, E. E. (2018). Prior experience with cardiovascular medicines predicted longer persistence in people initiated to combinations of antihypertensive and lipid-lowering therapies: findings from two Australian cohorts. Patient preference and adherence, 12, 835-843.
DOI Scopus3 WoS3 Europe PMC3 |
| 2018 |
Hoang, T., Liu, J., Pratt, N., Zheng, V. W., Chang, K. C., Roughead, E., & Li, J. (2018). Authenticity and credibility aware detection of adverse drug events from social media. International Journal of Medical Informatics, 120, 157-171.
DOI Scopus10 WoS5 Europe PMC2 |
| 2018 |
Widagdo, I. S., Pratt, N. L., & Roughead, E. E. (2018). The association between frailty and medicines use over time: an analysis using the Australian Longitudinal Study on Ageing population. Journal of Pharmacy Practice and Research, 48(5), 405-415.
DOI |
| 2018 |
Lai, E. C. C., Shin, J. Y., Kubota, K., Man, K. K. C., Park, B. J., Pratt, N., . . . Setoguchi, S. (2018). Comparative safety of NSAIDs for gastrointestinal events in Asia-Pacific populations: a multi-database, international cohort study. Pharmacoepidemiology and drug safety, 27(11), 1223-1230.
DOI Scopus12 WoS11 Europe PMC9 |
| 2018 |
Gillam, M., Inacio, M., Pratt, N., Shakib, S., & Roughead, E. (2018). Magnetic Resonance Imaging in People With Cardiac Implantable Electronic Devices: A Population Based Cohort Study. Heart Lung and Circulation, 27(6), 748-751.
DOI Scopus6 WoS6 Europe PMC5 |
| 2018 |
Nguyen, T. A., Pham, T., Vu, H. T. T., Nguyen, T. X., Vu, T. T., Nguyen, B. T. T., . . . Roughead, E. E. (2018). Use of potentially inappropriate medications in people with dementia in Vietnam and its associated factors. American Journal of Alzheimer's Disease and other Dementias, 33(7), 423-432.
DOI Scopus17 WoS14 Europe PMC11 |
| 2018 |
Inacio, M., Cashman, K., Pratt, N., Gillam, M., Caughey, G., Graves, S., & Roughead, E. (2018). Prevalence and changes in analgesic medication utilisation 1 year prior to total joint replacement in an older cohort of patients. Osteoarthritis and Cartilage, 26(3), 356-362.
DOI Scopus25 WoS24 Europe PMC18 |
| 2018 |
Hoang, T., Liu, J., Roughead, E., Pratt, N., & Li, J. (2018). Supervised signal detection for adverse drug reactions in medication dispensing data. Computer Methods and Programs in Biomedicine, 161, 25-38.
DOI Scopus29 WoS23 Europe PMC19 |
| 2018 |
Gillam, M., Pratt, N., Inacio, M., Shakib, S., Sanders, P., Lau, D., & Roughead, E. (2018). Rehospitalizations for complications and mortality following pacemaker implantation: a retrospective cohort study in an older population. Clinical Cardiology, 41(11), 1480-1486.
DOI Scopus15 WoS14 Europe PMC11 |
| 2018 |
Raman, S. R., Man, K. K. C., Bahmanyar, S., Berard, A., Bilder, S., Boukhris, T., . . . Wong, I. C. K. (2018). Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. The Lancet Psychiatry, 5(10), 824-835.
DOI Scopus258 WoS246 Europe PMC196 |
| 2018 |
Hoang, T., Liu, J., Pratt, N., Zheng, V. W., Chang, K. C., Roughead, E., & Li, J. (2018). Authenticity and credibility aware detection of adverse drug events from social media. International journal of medical informatics, 120, 157-171.
DOI Scopus5 WoS4 Europe PMC6 |
| 2018 |
Pratt, N., & Roughead, E. (2018). Assessment of Medication Safety Using Only Dispensing Data. CURRENT EPIDEMIOLOGY REPORTS, 5(4), 357-369.
DOI WoS13 Europe PMC12 |
| 2018 |
Kalisch Ellett, L., Pratt, N., & Roughead, E. (2018). Analgesic use in Vietnam veterans' with musculoskeletal pain. Journal of military and veterans' health, 26(3), 28-35.
WoS1 |
| 2018 |
Ramsay, E., Pratt, N., Moffat, A., Kalisch Ellett, L., & Roughead, E. (2018). Evaluating the assumptions of the self-controlled case series design in studies investigating the risks of antipsychotic use in the older population. Pharmacoepidemiology and drug safety, 27(S2, article no. 776), 354-355.
DOI |
| 2018 |
Pratt, N., Kerr, M., Barratt, J., Kemp Casey, A., Kalisch Ellett, L., Ramsay, E., & Roughead, E. (2018). The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) Classification System. BMJ open, 8(4), 1-8.
DOI Scopus227 WoS228 Europe PMC195 |
| 2018 |
Namba, R. S., Inacio, M. C. S., Pratt, N. L., Graves, S. E., Roughead, E. E., & Paxton, E. W. (2018). Persistent opioid use following total knee arthroplasty: a signal for close surveillance. Journal of arthroplasty, 33(2), 331-336.
DOI Scopus62 WoS55 Europe PMC48 |
| 2018 |
Kassie, G. M., Nguyen, T. A., Kalisch Ellett, L. M., Pratt, N. L., & Roughead, E. E. (2018). Do risk prediction models for postoperative delirium consider patients' preoperative medication use?. Drugs and aging, 35(3), 213-222.
DOI Scopus12 WoS12 Europe PMC10 |
| 2017 |
Kassie, G. M., Nguyen, T. A., Kalisch Ellett, L. M., Pratt, N. L., & Roughead, E. E. (2017). Preoperative medication use and postoperative delirium: a systematic review. BMC geriatrics, 17(article no. 298), 1-10.
DOI Scopus99 WoS85 Europe PMC72 |
| 2017 |
Gillam, M., Pratt, N., Inacio, M., Roughead, E., Shakib, S., Nicholls, S., & Graves, S. (2017). Heart failure after conventional metal-on-metal hip replacements: a retrospective cohort study. Acta Orthopaedica, 88(1), 2-9.
DOI Scopus26 WoS25 Europe PMC24 |
| 2017 |
Leach, M. J., Pratt, N. L., & Roughead, E. E. (2017). Risk of Hip Fracture in Older People Using Selective Serotonin Reuptake Inhibitors and Other Psychoactive Medicines Concurrently: A Matched Case–Control Study in Australia. Drugs - Real World Outcomes, 4(2), 87-96.
DOI Scopus14 Europe PMC11 |
| 2017 |
Pratt, N. L., & Roughead, E. E. (2017). Can we reduce the prevalence of persistent opioid use after surgery by predicting the future?. Anaesthesia and intensive care, 45(6), 658-659.
DOI Scopus1 WoS1 |
| 2017 |
Leach, M. J., Pratt, N. L., & Roughead, E. E. (2017). The risk of hip fracture due to mirtazapine exposure when switching antidepressants or using other antidepressants as add-on therapy. Drugs - real world outcomes, 4(4), 247-255.
DOI Scopus11 Europe PMC9 |
| 2017 |
Gadzhanova, S., Pratt, N., & Roughead, E. (2017). Use of SGLT2 inhibitors for diabetes and risk of infection: Analysis using general practice records from the NPS MedicineWise MedicineInsight program. Diabetes Research and Clinical Practice, 130, 180-185.
DOI Scopus50 WoS48 Europe PMC45 |
| 2017 |
Lai, E. C. C., Pratt, N., Hsieh, C. Y., Lin, S. J., Pottegård, A., Roughead, E. E., . . . Hallas, J. (2017). Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies. European Journal of Epidemiology, 32(7), 567-582.
DOI Scopus80 WoS76 Europe PMC58 |
| 2017 |
Inacio, M. C. S., Graves, S. E., Pratt, N. L., Roughead, E. E., & Nemes, S. (2017). Increase in total joint arthroplasty projected from 2014 to 2046 in Australia: a conservative local model with international implications. Clinical Orthopaedics and Related Research, 475(8), 2130-2137.
DOI Scopus171 WoS153 Europe PMC125 |
| 2017 |
Kalisch Ellett, L. M., Pratt, N. L., Sluggett, J. K., Ramsay, E. N., Kerr, M., LeBlanc, V. T., . . . Roughead, E. E. (2017). Patient-specific prescriber feedback can increase the rate of osteoporosis screening and treatment: results from two national interventions. Archives of osteoporosis, 12(1, article no. 17), 1-7.
DOI Scopus6 WoS6 Europe PMC5 |
| 2017 |
Roughead, E. E., Pratt, N. L., Kalisch Ellett, L. M., Ramsay, E. N., Barratt, J. D., Morris, P., & Killer, G. (2017). Posttraumatic Stress Disorder, Antipsychotic Use and Risk of Dementia in Veterans. Journal of the American Geriatrics Society, 65(7), 1521-1526.
DOI Scopus20 WoS20 Europe PMC17 |
| 2017 |
Pratt, N. L., Kalisch Ellett, L. M., Sluggett, J. K., Gadzhanova, S. V., Ramsay, E. N., Kerr, M., . . . Roughead, E. E. (2017). Use of proton pump inhibitors among older Australians: National quality improvement programmes have led to sustained practice change. International Journal for Quality in Health Care, 29(1), 75-82.
DOI Scopus27 WoS21 Europe PMC22 |
| 2017 |
Bartlett, L. E., Pratt, N., & Roughead, E. E. (2017). Does tablet formulation alone improve adherence and persistence: a comparison of ezetimibe fixed dose combination versus ezetimibe separate pill combination?. British Journal of Clinical Pharmacology, 83(1), 202-210.
DOI Scopus18 WoS17 Europe PMC17 |
| 2017 |
Hansen, C., Inacio, M., Pratt, N., Roughead, E., & Graves, S. (2017). Chronic use of opioids before and after total knee arthroplasty: a retrospective cohort study. Journal of Arthroplasty, 32(3), 811-817.e1.
DOI Scopus100 WoS95 Europe PMC76 |
| 2017 |
Caughey, G., Pratt, N., Barratt, J., Shakib, S., Kemp-Casey, A., & Roughead, E. (2017). Understanding 30-day re-admission after hospitalisation of older patients for diabetes: Identifying those at greatest risk. Medical Journal of Australia, 206(4), 170-175.
DOI Scopus26 WoS24 Europe PMC19 |
| 2016 |
Hoang, T., Liu, J., Pratt, N., Zheng, V. W., Chang, K. C., Roughead, E., & Li, J. (2016). Detecting signals of detrimental prescribing cascades from social media. Artificial Intelligence in Medicine, 71, 43-56.
DOI Scopus15 WoS13 Europe PMC8 |
| 2016 |
Roughead, E. E., Chan, E. W., Choi, N. K., Griffiths, J., Jin, X. M., Lee, J., . . . Pratt, N. L. (2016). Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis. Expert Opinion on Drug Safety, 15(12), 1589-1595.
DOI Scopus36 WoS33 Europe PMC32 |
| 2016 |
Inacio, M., Hansen, C., Pratt, N., Graves, S., & Roughead, E. (2016). Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: a retrospective cohort study. BMJ Open, 6(4), e010664-1-e010664-10.
DOI Scopus177 WoS165 Europe PMC149 |
| 2016 |
Pratt, N., Ramsay, E., Caughey, G., Shakib, S., & Roughead, E. (2016). Uptake of novel oral anticoagulants in Australia. Medical Journal of Australia, 204(3), 104-105.
DOI Scopus30 WoS26 Europe PMC21 |
| 2016 |
Inacio, M. C. S., Pratt, N. L., Roughead, E. E., & Graves, S. E. (2016). Response to Letter to the Editor: 'use of preoperative comorbidity scores to predict mortality after total arthroplasty'. Osteoarthritis and cartilage, 25(1), e7.
DOI |
| 2016 |
Namba, R. S., Inacio, M. C. S., Pratt, N. L., Graves, S. E., Roughead, E. E., Craig Cheetham, T., & Paxton, E. W. (2016). Postoperative opioid use as an early indication of total hip arthroplasty failure. Acta Orthopaedica, 87(eSuppl 362), 37-43.
DOI Scopus42 WoS35 Europe PMC33 |
| 2016 |
Kalisch Ellett, L. M., Pratt, N. L., Le, B. V. T., Westaway, K., & Roughead, E. E. (2016). Increased risk of hospital admission for dehydration or heat-related illness after initiation of medicines: a sequence symmetry analysis. Journal of clinical pharmacy and therapeutics, 41(5), 503-507.
DOI Scopus34 WoS25 Europe PMC26 |
| 2016 |
Wahab, I. A., Pratt, N. L., Ellett, L. K., & Roughead, E. E. (2016). Sequence symmetry analysis as a signal detection tool for potential heart failure adverse events in an administrative claims database. Drug Safety, 39(4), 347-354.
DOI Scopus20 WoS19 Europe PMC15 |
| 2016 |
Shin, J. Y., Roughead, E. E., Park, B. J., & Pratt, N. L. (2016). Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study. BMJ, 353(i2550), i2550-1-i2550-8.
DOI Scopus107 WoS94 Europe PMC75 |
| 2016 |
Inacio, M. C. S., Pratt, N. L., Roughead, E. E., & Graves, S. E. (2016). Evaluation of three co-morbidity measures to predict mortality in patients undergoing total joint arthroplasty. Osteoarthritis and Cartilage, 24(10), 1718-1726.
DOI Scopus32 WoS24 Europe PMC23 |
| 2016 |
Hripcsak, G., Ryan, P. B., Duke, J. D., Shah, N. H., Park, R. W., Huser, V., . . . Madigan, D. (2016). Characterizing treatment pathways at scale using the OHDSI network. Proceedings of the National Academy of Sciences of the United States of America, 113(27), 7329-7336.
DOI Scopus239 WoS206 Europe PMC199 |
| 2016 |
Kalisch Ellett, L. M., Pratt, N. L., Ramsay, E. N., Sluggett, J. K., Barratt, J. D., & Roughead, E. E. (2016). Central Nervous System-Acting Medicines and Risk of Hospital Admission for Confusion, Delirium, or Dementia. Journal of the American Medical Directors Association, 17(6), 530-534.
DOI Scopus9 WoS9 Europe PMC7 |
| 2016 |
Inacio, M. C. S., Pratt, N. L., Roughead, E. E., Paxton, E. W., & Graves, S. E. (2016). Opioid use after total hip arthroplasty surgery is associated with revision surgery. BMC Musculoskeletal Disorders, 17(1), 122-1-122-9.
DOI Scopus48 WoS43 Europe PMC43 |
| 2016 |
Widagdo, I. S., Pratt, N., Russell, M., & Roughead, E. E. (2016). Construct validity of four frailty measures in an older Australian population: a Rasch analysis. Journal of frailty & aging, 5(2), 78-81.
DOI Scopus17 WoS16 Europe PMC16 |
| 2015 |
Inacio, M. C. S., Pratt, N. L., Roughead, E. E., & Graves, S. E. (2015). Comparing co-morbidities in total joint arthroplasty patients using the RxRisk-V, Elixhauser, and Charlson Measures: a cross-sectional evaluation. BMC Musculoskeletal Disorders, 16(1), 385-1-385-9.
DOI Scopus27 WoS24 Europe PMC20 |
| 2015 |
Widagdo, I. S., Pratt, N., Russell, M., & Roughead, E. E. (2015). Predictive performance of four frailty measures in an older Australian population. Age and Ageing, 44(6), 967-972.
DOI Scopus35 WoS36 Europe PMC31 |
| 2015 |
Inacio, M. C. S., Pratt, N. L., Roughead, E. E., & Graves, S. E. (2015). Using medications for prediction of revision after total joint arthroplasty. Journal of Arthroplasty, 30(12), 2061-2070.
DOI Scopus11 WoS10 Europe PMC9 |
| 2015 |
Kalisch Ellett, L. M., Pratt, N. L., Ramsay, E. N., Barratt, J. D., & Roughead, E. E. (2015). Response to lertxundi and colleagues. Journal of the American geriatrics society, 63(5), 1054-1055.
DOI |
| 2015 |
Pratt, N., Chan, E. W., Choi, N. K., Kimura, M., Kimura, T., Kubota, K., . . . Roughead, E. E. (2015). Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries. Pharmacoepidemiology and Drug Safety, 24(8), 858-864.
DOI Scopus53 WoS48 Europe PMC38 |
| 2015 |
Widagdo, I., Pratt, N., Russell, M., & Roughead, E. (2015). How common is frailty in older Australians?. Australasian Journal on Ageing, 34(4), 247-251.
DOI Scopus16 WoS13 Europe PMC11 |
| 2015 |
Leach, M. J., Pratt, N. L., & Roughead, E. E. (2015). Psychoactive medicine use and the risk of hip fracture in older people: a case-crossover study. Pharmacoepidemiology and Drug Safety, 24(6), 576-582.
DOI Scopus17 WoS15 Europe PMC14 |
| 2015 |
Pratt, N. L., Kalisch Ellett, L. M., Sluggett, J. K., Ramsay, E. N., Kerr, M., LeBlanc, V. T., . . . Roughead, E. E. (2015). Commitment questions targeting patients promotes uptake of under-used health services: findings from a national quality improvement program in Australia. Social Science and Medicine, 145, 1-6.
DOI Scopus6 WoS6 Europe PMC6 |
| 2015 |
Roughead, E. E., Chan, E. W., Choi, N. K., Kimura, M., Kimura, T., Kubota, K., . . . Pratt, N. L. (2015). Variation in association between thiazolidinediones and heart failure across ethnic groups: retrospective analysis of large healthcare claims databases in six countries. Drug Safety, 38(9), 823-831.
DOI Scopus38 WoS35 Europe PMC29 |
| 2015 |
Pratt, N. L., Ramsay, E. N., Kalisch Ellett, L. M., Nguyen, T. A., & Roughead, E. E. (2015). Association between ophthalmic timolol and hospitalisation for bradycardia. Journal of ophthalmology, 2015(article no. 567387), 1-6.
DOI Scopus18 WoS14 Europe PMC11 |
| 2015 |
Hripcsak, G., Duke, J. D., Shah, N. H., Reich, C. G., Huser, V., Schuemie, M. J., . . . Ryan, P. B. (2015). Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Studies in Health Technology and Informatics, 216, 574-578.
DOI Scopus960 WoS868 Europe PMC815 |
| 2015 |
Ellett, L. M. K., Pratt, N. L., Ramsay, E. N., Barratt, J. D., & Roughead, E. E. (2015). Re: Multiple Anticholinergic Medication Use and Risk of Hospital Admission for Confusion or Dementia Editorial Comment. JOURNAL OF UROLOGY, 194(5), 1353.
DOI |
| 2015 |
Roughead, E. E., & Pratt, N. L. (2015). Impact on drug safety of variation in adherence: the need for routinely reporting measures of dose Intensity in medication safety studies using electronic health data. Drug Safety, 38(12), 1145-1152.
DOI Scopus2 WoS2 Europe PMC1 |
| 2015 |
Inacio, M. C. S., Pratt, N. L., Roughead, E. E., & Graves, S. E. (2015). Predicting infections after total joint arthroplasty using a prescription based comorbidity measure. The Journal of Arthroplasty, 30(10), 1692-1698.
DOI Scopus19 WoS14 Europe PMC16 |
| 2015 |
Lai, E. C. C., Man, K. K. C., Chaiyakunapruk, N., Cheng, C. L., Pratt, N., Roughead, L., & Setoguchi, S. (2015). Databases in the Asia-Pacific region: the potential for a distributed network approach. Epidemiology, 26(6), 815-820.
DOI Scopus55 WoS51 Europe PMC37 |
| 2015 |
Nguyen, T., Caughey, G., Pratt, N., Shakib, S., Kemp, A., & Roughead, E. (2015). Hospitalization for drug-induced hepatotoxicity: linking Y-codes with pharmaceutical claims data to identify implicated medicines. Journal of Clinical Pharmacy and Therapeutics, 40(2), 213-219.
DOI Scopus2 WoS2 Europe PMC2 |
| 2015 |
Marsh-Tootle, W. L., Russ, S. A., Repka, M. X., Block, S. S., Miller, J. M., Walker, M., . . . Wallace, D. K. (2015). Vision and eye health in children 36 to G72 Months: Proposed data definitions. Optometry and Vision Science, 92(1), 17-23.
DOI Scopus10 Europe PMC8 |
| 2015 |
Hartmann, E. E., Block, S. S., Wallace, D. K., Russ, S. A., Miller, J. M., Walker, M., . . . Repka, M. X. (2015). Vision and eye health in children 36 to <72 months: Proposed data system. Optometry and Vision Science, 92(1), 24-30.
DOI Scopus20 Europe PMC16 |
| 2015 |
Cotter, S. A., Cyert, L. A., Miller, J. M., Quinn, G. E., Russ, S. A., Block, S. S., . . . Wallace, D. K. (2015). Vision screening for children 36 to G72 Months: Recommended practices. Optometry and Vision Science, 92(1), 6-16.
DOI Scopus107 Europe PMC79 |
| 2014 |
Leach, M. J., Pratt, N. L., & Roughead, E. E. (2014). Medicine use among the elderly before and after hip fracture. The Australian journal of pharmacy, 95(1125), 72-74. |
| 2014 |
Pratt, N., Graves, S., Cashman, K., Caughey, G., & Roughead, E. (2014). Anti-Coagulation After Hip or Knee Joint Replacement: Assessment of the Benefits and Risks in an Elderly Cohort. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 23, 485-486. |
| 2014 |
Pratt, N., Ramsay, E., Kemp, A., Kalisch-Ellett, L., Shakib, S., Caughey, G., . . . Roughead, E. (2014). Ranibizumab and risk of hospitalisation for ischaemic stroke and myocardial infarction in patients with age-related macular degeneration: a self-controlled case-series analysis. Drug Safety, 37(12), 1021-1027.
DOI Scopus17 WoS13 Europe PMC14 |
| 2014 |
Kalisch Ellett, L. M., Pratt, N. L., Ramsay, E. N., Barratt, J. D., & Roughead, E. E. (2014). Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia. Journal of the American Geriatric Society, 62(10), 1916-1922.
DOI Scopus105 WoS88 Europe PMC77 |
| 2014 |
Pratt, N. L., Ramsay, E. N., Kalisch Ellett, L. M., Nguyen, T. A., Barratt, J. D., & Roughead, E. E. (2014). Association between use of multiple psychoactive medicines and hospitalization for falls : retrospective analysis of a large healthcare claim database. Drug safety, 37(7), 529-535.
DOI Scopus35 WoS33 Europe PMC28 |
| 2014 |
Pratt, N. L., Ilomäki, J., Raymond, C., & Roughead, E. E. (2014). The performance of sequence symmetry analysis as a tool for post-market surveillance of newly marketed medicines : a simulation study. BMC medical research methodology, 14(article no. 66), 9 pages.
DOI Scopus37 WoS32 Europe PMC27 |
| 2014 |
Kalisch Ellett, L. M., Pratt, N. L., Barratt, J. D., Rowett, D., & Roughead, E. E. (2014). Risk of medication-associated initiation of oxybutynin in elderly men and women. Journal of the American Geriatrics Society, 62(4), 690-695.
DOI Scopus22 WoS20 Europe PMC16 |
| 2014 |
Wahab, I. A., Pratt, N. L., Kalisch, L. M., & Roughead, E. E. (2014). Comparing time to adverse drug reaction signals in a spontaneous reporting database and a claims database : a case study of rofecoxib-induced myocardial infarction and rosiglitazone-induced heart failure signals in Australia. Drug safety, 37(1), 53-64.
DOI Scopus33 WoS32 Europe PMC24 |
| 2013 |
Wahab, I. A., Pratt, N. L., Wiese, M. D., Kalisch, L. M., & Roughead, E. E. (2013). The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection. Pharmacoepidemiology and drug safety, 22(5), 496-502.
DOI Scopus69 WoS62 Europe PMC59 |
| 2013 |
Leach, M. J., Pratt, N. L., & Roughead, E. E. (2013). Medicine use among older Australians before and after hip fracture. Journal of pharmacy practice and research, 43(4), 265-268.
DOI Scopus6 |
| 2013 |
Wahab, I. A., Pratt, N. L., Kalisch Ellett, L. M., & Roughead, E. E. (2013). The detection of adverse events in randomized clinical trials : can we really say new medicines are safe?. Current drug safety, 8(2), 104-113.
DOI Scopus13 WoS13 Europe PMC11 |
| 2013 |
Kalisch Ellett, L. M., Pratt, N. L., Barratt, J. D., & Roughead, E. E. (2013). Urinary incontinence: a poorly recognised adverse effect of medicines. Pharmacoepidemiology and drug safety, 22(s1, article no. 948), 475. |
| 2013 |
Pratt, N., Ilomaki, J., Raymond, C., & Roughead, E. (2013). Validation of the adjusted sequence ratio in prescription sequence symmetry analysis: a simulation study. Pharmacoepidemiology and drug safety, 22(s1, article no. 464), 228-229. |
| 2013 |
Wang, T., Pratt, N., Killer, G., Roughead, E. E., & Griffiths, J. (2013). Proton pump inhibitors and clostridium difficile-associated disease in Canadian and Australian community settings - a prescription sequence symmetry analysis. Pharmacoepidemiology and drug safety, 22(s1, article no. 384), 187-188. |
| 2013 |
Pratt, N., Andersen, M., Bergman, U., Choi, N. K., Gerhard, T., Huang, C., . . . Roughead, E. E. (2013). Multi-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study. Pharmacoepidemiology and Drug Safety, 22(9), 915-924.
DOI Scopus52 WoS47 Europe PMC43 |
| 2013 |
Anderson, M., Bergman, U., Choi, N. K., Gerhard, T., Huang, C., Jalbert, J., . . . Yang, Y. H. K. (2013). The Asian Pharmacoepidemiology Network (AsPEN) : promoting multi-national collaboration for pharmacoepidemiologic research in Asia. Pharmacoepidemiology and drug safety, 22(7), 700-704.
DOI Scopus66 WoS55 Europe PMC49 |
| 2013 |
Roughead, E., Kalisch Ellett, L., Ramsay, E., Pratt, N., Barratt, J., LeBlanc, V., . . . Gilbert, A. (2013). Bridging evidence-practice gaps: improving use of medicines in elderly Australian veterans. BMC Health Services Research, 13(article no. 514), 1-14.
DOI Scopus29 WoS28 Europe PMC25 |
| 2013 |
Ramsay, E., Pratt, N., Ryan, P., & Roughead, E. (2013). Proton pump inhibitors and the risk of pneumonia: A comparison of cohort and self-controlled case series designs. BMC Medical Research Methodology, 13(1), 1-7.
DOI Scopus24 WoS23 Europe PMC21 |
| 2013 |
Wahab, I. A., Pratt, N. L., Kalisch Ellett, L. M., & Roughead, E. E. (2013). Sequence symmetry analysis and disproportionality analyses: what percentage of adverse drug reaction do they signal?. Advances in pharmacoepidemiology & drug safety, 2(4), 1-5.
DOI |
| 2012 |
Pratt, N., Roughead, E., Salter, A., & Ryan, P. (2012). Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review. BMC Medical Research Methodology, 12(1), 1-19.
DOI Scopus43 WoS39 Europe PMC32 |
| 2012 |
Roughead, E. E., Kalisch Ellett, L. M., Pratt, N. L., Killer, G., Barnard, A., & Gilbert, A. L. (2012). Managing glaucoma in those with co-morbidity : not as easy as it seems. Ophthalmic Epidemiology, 19(2), 74-82.
DOI Scopus33 WoS26 Europe PMC22 |
| 2011 |
Caughey, G. E., Roughead, E. E., Pratt, N. L., Killer, G., & Gilbert, A. L. (2011). Stroke risk and NSAIDs: an Australian population-based study. Medical journal of Australia, 195(9), 525-529.
DOI Scopus53 WoS39 Europe PMC30 |
| 2011 |
Woodward, M. C., Roughead, E. E., Kalisch, L. M., Pratt, N. L., & Le, B. V. T. (2011). Urinary incontinence - are medicines contributing to the problem?. Australasian journal on ageing, 30(1), 28.
DOI |
| 2011 |
Ramsay, E., Roughead, E., Ewald, B., Pratt, N., & Ryan, P. (2011). A self-controlled case series to assess the effectiveness of beta blockers for heart failure in reducing hospitalisations in the elderly. BMC Medical Research Methodology, 11(106), 106-1-106-7.
DOI Scopus7 WoS7 Europe PMC6 |
| 2011 |
Pratt, N., Roughead, E., Ramsay, E., Salter, A., & Ryan, P. (2011). Risk of hospitalization for hip fracture and pneumonia associated with antipsychotic prescribing in the elderly: A self-controlled case-series analysis in an Australian health care claims database. Drug Safety, 34(7), 567-575.
DOI Scopus72 WoS65 Europe PMC59 |
| 2011 |
Costain, D., Whitehouse, S., Pratt, N., Graves, S., Ryan, P., & Crawford, R. (2011). Perioperative mortality after hemiarthroplasty related to fixation method: A study based on the Australian Orthopaedic Association National Joint Replacement Registry. Acta Orthopaedica, 82(3), 275-281.
DOI Scopus83 WoS73 Europe PMC68 |
| 2011 |
Roughead, E., Barratt, J., Ramsay, E., Pratt, N., Ryan, P., Peck, R., . . . Gilbert, A. (2011). Collaborative home medicines review delays time to next hospitalization for warfarin associated bleeding in Australian war veterans. Journal of Clinical Pharmacy and Therapeutics, 36(1), 27-32.
DOI Scopus52 WoS39 Europe PMC31 |
| 2011 |
Bell, J. S., Kalisch Ellett, L. M., Ramsay, E. N., Pratt, N. L., Barratt, J. D., Le, B. T., . . . Gilbert, A. L. (2011). Prescriber feedback to improve quality use of medicines among older people: the veterans' MATES program. Journal of pharmacy practice and research, 41(4), 316-319.
DOI Scopus13 |
| 2010 |
Pratt, N., Roughead, E., Salter, A., & Ryan, P. (2010). Factors associated with choice of antipsychotic treatment in elderly veterans: potential confounders for observational studies. Australian and New Zealand Journal of Public Health, 34(6), 589-593.
DOI Scopus5 WoS5 Europe PMC4 |
| 2010 |
Pratt, N., Roughead, E., Ramsay, E., Salter, A., & Ryan, P. (2010). Risk of hospitalization for stroke associated with antipsychotic use in the elderly: A self-controlled case series. Drugs & Aging, 27(11), 885-893.
DOI Scopus34 WoS32 Europe PMC30 |
| 2010 |
Caughey, G., Roughead, E., Pratt, N., Shakib, S., Vitry, A., & Gilbert, A. (2010). Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing?. Pharmacoepidemiology and Drug Safety, 19(9), 977-982.
DOI Scopus62 WoS57 Europe PMC46 |
| 2010 |
Pratt, N., Roughead, E., Ryan, P., & Salter, A. (2010). Antipsychotics and the risk of death in the elderly: an instrumental variable analysis using two preference based instruments. Pharmacoepidemiology and Drug Safety, 19(7), 699-707.
DOI Scopus30 WoS28 Europe PMC28 |
| 2010 |
Pratt, N., Roughead, E., Ryan, P., & Gilbert, A. (2010). Differential impact of NSAIDs on rate of adverse events that require hospitalization in high-risk and general veteran populations: A retrospective cohort study. Drugs & Aging, 27(1), 63-71.
DOI Scopus23 WoS18 Europe PMC17 |
| 2010 |
Lie, S., Pratt, N., Ryan, P., Engesaeter, L., Havelin, L., Furnes, O., & Graves, S. (2010). Duration of the Increase in Early Postoperative Mortality After Elective Hip and Knee Replacement. Journal of Bone and Joint Surgery-American Volume, 92(1), 58-63.
DOI Scopus63 WoS59 Europe PMC45 |
| 2010 |
Pratt, N. (2010). Histamine H2 receptor antagonists and proton pump inhibitors: best options for gastro-oesophageal reflux in children. Drugs and Therapy Perspectives, 26(2), 18-21.
DOI |
| 2009 |
Roughead, E., Barratt, J., Ramsay, E., Pratt, N., Ryan, P., Peck, R., . . . Gilbert, A. (2009). The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study. Circulation. Heart Failure, 2(5), 424-428.
DOI Scopus121 WoS90 Europe PMC77 |
| 2009 |
Roughead, E., Ramsay, E., Pratt, N., Ryan, P., & Gilbert, A. (2009). Proton-pump inhibitors and the risk of antibiotic use and hospitalisation for pneumonia. Medical Journal of Australia, 190(3), 114-116.
DOI Scopus28 WoS23 Europe PMC20 |
| 2009 |
Pratt, N., Roughead, E., Ryan, P., Peck, R., & Gilbert, A. (2009). Antipsychotics and the Risk of Hip Fracture, Pneumonia and Stroke: Self-Controlled Case Series and Instrumental Variable Analysis Results. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 18, S108. |
| 2009 |
Gilbert, A. L., Roughead, E. E., Barratt, J. D., Ramsey, E., Pratt, N., Ryan, P., . . . Killer, G. (2009). The Effectiveness of Collaborative Medicine Reviews in Delaying Time to Next Hospitalisation for Heart Failure Patients in the Ambulatory Setting: Results of a Cohort Study. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 18, S122. |
| 2008 |
Roughead, E., Ramsay, E., Pratt, N., & Gilbert, A. (2008). NSAID use in individuals at risk of renal adverse events an observational study to investigate trends in Australian veterans. Drug Safety, 31(11), 997-1003.
DOI Scopus19 WoS16 Europe PMC13 |
| 2008 |
Conroy, J., Whitehouse, S., Graves, S., Pratt, N., Ryan, P., & Crawford, R. (2008). Risk factors for revision for early dislocation in total hip arthroplasty. Journal of Arthroplasty, 23(6), 867-872.
DOI Scopus125 WoS111 Europe PMC103 |
| 2007 |
Roughead, E., Pratt, N., Peck, R., & Gilbert, A. (2007). Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners. Pharmacoepidemiology and Drug Safety, 16(7), 797-803.
DOI Scopus24 WoS23 Europe PMC20 |
| 2007 |
Roughead, E., Pratt, N., & Gilbert, A. (2007). Trends over 5 years in cardiovascular medicine use in Australian veterans with diabetes. British Journal of Clinical Pharmacology, 64(1), 100-104.
DOI Scopus6 WoS6 Europe PMC5 |
| 2007 |
Hong, Q., Hsu, L. J., Schultz, L., Pratt, N., Mattison, J., & Chang, N. S. (2007). Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-κB, JNK1, p53 and WOX1 during stress response. BMC Molecular Biology, 8(1), 17 pages.
DOI Scopus42 WoS37 Europe PMC39 |
| 2006 |
Gun, R., Pratt, N., & Ryan, P. (2006). Tobacco and alcohol-related mortality in men: estimates from the Australian cohort of petroleum industry workers. Australian and New Zealand Journal of Public Health, 30(4), 318-324.
DOI Scopus8 WoS8 Europe PMC6 |
| 2006 |
Gun, R., Pratt, N., Ryan, P., & Roder, D. (2006). Update of mortality and cancer incidence in the Australian petroleum industry cohort. Occupational and Environmental Medicine, 63(7), 476-481.
DOI Scopus62 WoS60 Europe PMC51 |
| 2006 |
Gun, R., Pratt, N., Roder, D., & Ryan, P. (2006). Asbestos-related cancers in refinery workers in the Australian petroleum industry. Archives of Environmental Health, 61(1), 11-16.
DOI Scopus11 WoS6 Europe PMC6 |
| 2005 |
Clark, S., Marley, J., Hiller, J., Leahy, C., & Pratt, N. (2005). A grief diagnostic instrument for general practice. Omega-Journal of Death and Dying, 52(2), 169-195.
DOI Scopus17 WoS17 |
| 2005 |
Walker, R., Turnbull, D., Pratt, N., & Wilkinson, C. (2005). The development and process evaluation of an information-based intervention for pregnant women aimed at addressing rates of caesarean section. BJOG, 112(12), 1605-1614.
DOI Scopus5 WoS6 Europe PMC5 |
| 2005 |
Osti, O., Gun, R., Abraham, G., Pratt, N., Eckerwall, C., & Nakamura, H. (2005). Potential risk factors for prolonged recovery following whiplash injury. European Spine Journal, 14(1), 90-94.
DOI Scopus30 WoS22 Europe PMC18 |
| 2004 |
Graves, S., Davidson, D., Ingerson, L., Ryan, P., Griffith, E., McDermott, B., & Pratt, N. (2004). The Australian Orthopaedic Association National Joint Replacement Registry. Medical Journal of Australia, 180(5), S31-S34.
DOI Scopus162 WoS138 Europe PMC142 |
| 2004 |
Gunn, R., Pratt, N., Griffith, E., Adams, G., Bisby, J., & Robinson, K. (2004). Update of a prospective study of mortality and cancer incidence in the Australian petroleum industry. Occupational and Environmental Medicine, 61(2), 150-156.
DOI Scopus48 WoS46 Europe PMC39 |
| 2003 |
Rogers, G., Curry, M., Oddy, J., Pratt, N., Beilby, J., & Wilkinson, D. (2003). Depressive disorders and unprotected casual anal sex among Australian homosexually active men in primary care. HIV Medicine, 4(3), 271-275.
DOI Scopus68 Europe PMC52 |
| 2003 |
Gialamas, A., Beilby, J., Pratt, N., Henning, R., Marley, J., & Roddick, J. (2003). Investigating tiredness in Australian general practice - Do pathology tests help in diagnosis?. Australian Family Physician, 32(8), 663-666.
Scopus21 Europe PMC10 |
| 2003 |
Wilkinson, D., Laven, G., Pratt, N., & Beilby, J. (2003). Impact of undergraduate and postgraduate rural training, and medical school entry criteria on rural practice among Australian general practitioners: national study of 2414 doctors. Medical Education, 37(9), 809-814.
DOI Scopus133 WoS132 Europe PMC90 |
| 2002 |
Martin, A., Pratt, N., Kennedy, J., Ryan, P., Ruffin, R., Miles, H., & Marley, J. (2002). Natural history and familial relationships of infant spilling to 9 years of age. Pediatrics, 109(6), 1061-1067.
DOI Scopus193 WoS151 Europe PMC120 |
| 2002 |
Beilby, J., Marley, J., Walker, D., Chamberlain, N., & Burke, M. (2002). Effect of changes in antibiotic prescribing on patient outcomes in a community setting: A natural experiment in Australia. Clinical Infectious Diseases, 34(1), 55-64.
DOI Scopus31 WoS22 Europe PMC16 |
| 2001 |
Duszynski, K., Beilby, J., Marley, J., Walker, D., & Pratt, N. (2001). Privacy considerations in the context of an Australian observational database. Pharmacoepidemiology and Drug Safety, 10(7), 587-594.
DOI Scopus2 Europe PMC1 |
| 2001 |
Walker, D., Duszynski, K., Beilby, J., Pratt, N., & Marley, J. (2001). Management of clinical data - issues from a research perspective. Drug Information Journal, 35(3), 655-663.
DOI |
| 2001 |
Marley, J., Searle, P., Chamberlain, N., Turnbull, D., & Leahy, C. (2001). Carols in the wind. Medical Journal of Australia, 175(11), 656-658.
DOI Scopus2 |
| 2001 |
Chang, N. S., Pratt, N., Heath, J., Schultz, L., Sleve, D., Carey, G. B., & Zevotek, N. (2001). Hyaluronidase Induction of a WW Domain-containing Oxidoreductase that Enhances Tumor Necrosis Factor Cytotoxicity. Journal of Biological Chemistry, 276(5), 3361-3370.
DOI Scopus196 Europe PMC178 |
| 2000 |
Cao, H., Pratt, N., Mattison, J., Zhao, Y., & Chang, N. S. (2000). Characterization of an apoptosis inhibitory domain at the C-termini of FE65-like protein. Biochemical and Biophysical Research Communications, 276(3), 843-850.
DOI Scopus5 Europe PMC4 |
| 2000 |
Wilkinson, D., Beilby, J., Thompson, D., Laven, G., Pratt, N., & Laurence, C. (2000). Associations between rural background and where South Australian general practitioners work. Medical Journal of Australia, 173(3), 137-140.
DOI Scopus29 WoS26 Europe PMC25 |
| 1998 |
Chang, N. S., Mattison, J., Cao, H., Pratt, N., Zhao, Y., & Lee, C. (1998). Cloning and characterization of a novel transforming growth factor-β1-induced TIAF1 protein that inhibits tumor necrosis factor cytotoxicity. Biochemical and Biophysical Research Communications, 253(3), 743-749.
DOI Scopus31 Europe PMC28 |
